Tisdag 26 November | 06:50:01 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-02-13 08:00 Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-15 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2024-05-14 - Årsstämma
2024-05-14 - Kvartalsrapport 2024-Q1
2024-02-21 - Extra Bolagsstämma 2024
2024-02-15 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-09-28 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-12 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2023-05-11 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-12-09 - Extra Bolagsstämma 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-12 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2022-05-11 - Årsstämma
2022-05-11 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-23 - Extra Bolagsstämma 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-12 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2021-05-11 - Årsstämma
2021-05-11 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-08-11 - Extra Bolagsstämma 2020
2020-05-15 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2020-05-14 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-08-16 - Extra Bolagsstämma 2019
2019-05-17 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2019-05-16 - Årsstämma
2019-05-16 - Kvartalsrapport 2019-Q1
2019-02-20 - Bokslutskommuniké 2018
2018-11-14 - Kvartalsrapport 2018-Q3
2018-08-21 - Kvartalsrapport 2018-Q2
2018-05-24 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2018-05-23 - Årsstämma
2018-05-23 - Kvartalsrapport 2018-Q1
2018-02-26 - Bokslutskommuniké 2017
2017-11-14 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-26 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2017-05-24 - Årsstämma
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Acarix är ett diagnostikbolag. Bolaget har utvecklat en teknologi som möjliggör identifiering av kranskärlssjukdomar. Bolagets produkt är ett icke-invasivt test som sätts med en lapp på patienten för att analysera ljud från hjärtat. Idag innehas verksamhet främst inom den nordiska marknaden. Bolaget grundades under 2009 som en avknoppning från Coloplast. Huvudkontoret ligger i Malmö.
2024-05-13 09:45:00

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced that the CADScor System is now available at multiple clinics within Miami's Amavita Heart and Vascular Health™, a leading cardiovascular practice.

“We take pride in our ability to offer state-of-the-art testing and diagnostics while providing value-based quality care to our patients,” stated Dr. Pedro Martinez-Clark, MD, FACC, founder and interventional cardiologist. “Incorporating the CADScor System into the diagnostic toolbox allows us to provide patients with suspected coronary artery disease a fast and easy test with results at the point of care. We acknowledge that waiting for results can be an anxiety-inducing experience for patients, so we have minimized the wait time by including the CADScor System in our diagnostic workflow. Instead of our patients waiting to receive results, they can immediately start working with our team to focus on the next steps to address their needs.”

Amavita Heart and Vascular Health™ operates several locations throughout Miami-Dade County, enabling the practice to serve patients across South Florida. Their main objective is to enhance cardiovascular outcomes using advanced technology and interventions while providing empathetic care to all patients.

“We are pleased to announce the incorporation of the CADScor System within an advanced facility like Amavita Heart and Vascular Health™,” commented Acarix President & CEO Aamir Mahmood. “The CADScor System represents a pivotal step towards value-based care in cardiology. Providing an accurate and non-invasive tool for risk stratification of coronary artery disease at the point of care empowers clinicians to tailor decisions more precisely, leading to better outcomes and cost-effective care. This technology enhances the patient experience by minimizing unnecessary procedures and aligns with the healthcare industry's shift towards value-driven practices, where quality and efficiency are paramount.”